UnifiedOnline Inc fka UOIP

[Goodbuddy4863]

COVID-19 Update:

FDA SAYS THERE'S A SHORTAGE OF HYDROXYCHLOROQUINE AND CHLOROQUINE 'DUE TO A SIGNIFICANT SURGE IN DEMAND:

https://www.newsweek.com/fda-shortage-hydroxychloroquine-chloroquine-1495555

The U.S. is facing shortages of antimalarial drugs being used experimentally to treat COVID-19 patients, according to the Food and Drug Administration (FDA).

Both hydroxychloroquine and chloroquine, which are used to treat malaria, lupus and rheumatoid arthritis, are listed as "currently in shortage" by the agency. This is "due to a significant surge in demand," the body said.

The FDA stated: "all manufacturers are ramping up production" and the agency is ensuring this is happening "expeditiously and safely."

RELATED STORIES
Losing Sense of Smell, Taste 'Strong Predictor' Coronavirus Infection
Coronavirus Death Rate Could Be Way Lower Than Previously Thought: Study
CDC Director Says There May Be Second Coronavirus Wave in Late Fall
The announcement follows FDA approval of the drugs for use in patients hospitalized by and in clinical trials for the treatment of COVID-19, after it issued the first Emergency Use Authorization for a drug related to the disease over the weekend.

Ads by scrollerads.com
The U.S. Department of Health and Human Services (HHS) said in a statement on Sunday that it accepted 30 million doses of hydroxychloroquine sulfate from an arm of the pharmaceutical company Novartis, and one million of chloroquine phosphate from Bayer Pharmaceuticals.

On Wednesday, the FDA said the 30 million doses "is expected to help ease supply pressures for the drugs.

"This is a fluctuating and dynamic situation and the FDA is actively engaged. The agency is updating its shortages lists regularly and continuing to communicate in real-time so that patients and healthcare providers have the most current information on product shortages in the U.S."
________________________________________________